These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1649715)

  • 1. Effect of acute administration of gliclazide on the glucose sensitivity of pancreatic B-cells in healthy subjects.
    Veneman TF; van Haeften TW; van der Veen EA
    Clin Sci (Lond); 1991 Jul; 81(1):101-6. PubMed ID: 1649715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of gliclazide on glucose-stimulated insulin release in man.
    van Haeften TW; Veneman TF; Gerich JE; van der Veen EA
    Metabolism; 1991 Jul; 40(7):751-5. PubMed ID: 1870430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gliclazide at a lower concentration than therapeutic dose increases the sensitivity of insulin secretion to glucose in perfused rat pancreas.
    Mokuda O; Tanaka H; Hayashi T; Ooka H; Okazaki R
    Diabetes Metab; 2004 Apr; 30(2):193-6. PubMed ID: 15223993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gliclazide treatment on insulin secretion and beta-cell mass in non-insulin dependent diabetic Goto-Kakisaki rats.
    Dachicourt N; Bailbé D; Gangnerau MN; Serradas P; Ravel D; Portha B
    Eur J Pharmacol; 1998 Nov; 361(2-3):243-51. PubMed ID: 9865514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of pancreatic beta-cell secretion in Type 2 diabetic patients treated with gliclazide and glibenclamide.
    van der Wal PS; Heine RJ
    Diabetes Res Clin Pract; 2001 May; 52(2):103-11. PubMed ID: 11311964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The physiological action of gliclazide: beta-cell function and insulin resistance.
    Matthews DR; Hosker JP; Stratton I
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S53-9. PubMed ID: 1794266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliclazide mainly affects insulin secretion in second phase of type 2 diabetes mellitus.
    Ligtenberg JJ; Reitsma WD; van Haeften TW
    Horm Metab Res; 2001 Jun; 33(6):361-4. PubMed ID: 11456286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased insulin secretory capacity and normal pancreatic B-cell glucose sensitivity in non-obese patients with NIDDM.
    Van Haeften TW; Van Maarschalkerweerd WW; Gerich JE; Van der Veen EA
    Eur J Clin Invest; 1991 Apr; 21(2):168-74. PubMed ID: 1905629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
    Serradas P; Bailbé D; Portha B
    Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response characteristics for arginine-stimulated insulin secretion in man and influence of hyperglycemia.
    van Haeften TW; Voetberg GA; Gerich JE; van der Veen EA
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1059-64. PubMed ID: 2677037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of gliclazide on plasma insulin, intact and 32/33 split proinsulin in South Asian subjects with Type 2 diabetes mellitus.
    Ammari F; Davies MJ; Koppiker N; Gregory R; Burden AC
    Diabet Med; 1999 Feb; 16(2):142-6. PubMed ID: 10229308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy.
    Hosker JP; Rudenski AS; Burnett MA; Matthews DR; Turner RC
    Metabolism; 1989 Aug; 38(8):767-72. PubMed ID: 2668699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in insulin secretion and calcium distribution within B cells induced by gliclazide.
    Semino MC; de Gagliardino EE; Gagliardino JJ
    Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):787-91. PubMed ID: 3326990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the cationic and secretory response of pancreatic islets to gliclazide and/or potassium.
    Mathias PC; Billaudel B; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):389-400. PubMed ID: 6320319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term gliclazide effects on pancreatic islet cell function and hepatic insulin extraction in non-insulin-dependent diabetes mellitus.
    Wajchenberg BL; Santomauro AT; Giannella-Neto D; Borghi VC; Porrelli RN
    Diabetes Res Clin Pract; 1992 Aug; 17(2):89-97. PubMed ID: 1425152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of cellular actions between gliclazide and a hypoglycaemic peptide fragment of human growth hormone (hGH 6-13).
    Ng FM
    Diabetes Res Clin Pract; 1988 May; 5(1):17-24. PubMed ID: 3042343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mode of action and clinical pharmacology of gliclazide: a review.
    Campbell DB; Lavielle R; Nathan C
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S21-36. PubMed ID: 1794262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 6-month gliclazide treatment on insulin release and sensitivity to endogenous insulin in NIDDM: role of initial continuous subcutaneous insulin infusion-induced normoglycemia.
    Della Casa L; del Rio G; Glaser B; Cerasi E
    Am J Med; 1991 Jun; 90(6A):37S-45S. PubMed ID: 1872303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.